Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.59 USD | +0.08% | +0.16% | +58.65% |
Jun. 11 | Ono Pharmaceutical Closes Deciphera Deal for About $2.4 Billion | DJ |
Jun. 11 | Deciphera Pharmaceuticals, Inc. Announces Board and Committee Changes | CI |
Business Summary
Number of employees: 355
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Switch Control Kinase Inhibitor Platform
100.0
%
| 126 | 100.0 % | 159 | 100.0 % | +26.75% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
76.4
%
| 97 | 77.5 % | 122 | 76.4 % | +25.03% |
Rest of World
12.3
%
| 14 | 11.1 % | 20 | 12.3 % | +39.91% |
Germany
11.3
%
| 14 | 11.4 % | 18 | 11.3 % | +25.58% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Steven Hoerter
CEO | Chief Executive Officer | 53 | 18-05-16 |
Tucker Kelly
DFI | Director of Finance/CFO | 53 | 15-01-31 |
Kevin Brodbeck
CTO | Chief Tech/Sci/R&D Officer | - | 22-12-31 |
Chief Tech/Sci/R&D Officer | - | 16-12-31 | |
Dashyant Dhanak
CTO | Chief Tech/Sci/R&D Officer | 61 | 23-09-04 |
Matthew Sherman
CTO | Chief Tech/Sci/R&D Officer | 68 | 19-10-01 |
Lisa Amaya Price
HRO | Human Resources Officer | - | 21-12-31 |
Kelley Dealhoy
PRN | Corporate Officer/Principal | - | 22-06-15 |
Jama Pitman
PRN | Corporate Officer/Principal | 45 | 14-12-31 |
Daniel Martin
PRN | Corporate Officer/Principal | 49 | 18-09-17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Hoerter
CEO | Chief Executive Officer | 53 | 18-05-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 86,475,972 | 61,844,480 ( 71.52 %) | 0 | 71.52 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+58.65% | 2.21B | |
+17.73% | 124B | |
+16.88% | 111B | |
-9.04% | 23.17B | |
+4.43% | 22.94B | |
-38.15% | 17.42B | |
-7.75% | 17.42B | |
-15.48% | 16.9B | |
+3.42% | 13.71B | |
+29.63% | 11.82B |
- Stock Market
- Equities
- DCPH Stock
- Company Deciphera Pharmaceuticals, Inc.